Continual advancements in cardiac imaging technologies contribute to improved diagnostic accuracy, early disease detection, and better patient outcomes. Positron emission tomography (PET) imaging, for instance, provides functional information about myocardial metabolism and blood flow, aiding in the assessment of heart conditions. 3D echocardiography enhances the visualization of cardiac structures, allowing for more precise evaluation of heart valve function and anatomical anomalies. Cardiac imaging is not only valuable in the diagnostic phase but also plays a vital role in guiding interventional procedures, such as angioplasty or transcatheter valve replacement. The integration of artificial intelligence (AI) in cardiac imaging further enhances efficiency and accuracy by assisting in image analysis and interpretation. As the field continues to evolve, cardiac imaging remains an indispensable tool in the comprehensive care of individuals with cardiovascular diseases, enabling healthcare providers to make informed decisions and tailor treatment strategies to each patient's specific needs.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation